Korean J Intern Med.  2016 Mar;31(2):406-408. 10.3904/kjim.2014.353.

Mixed-phenotype acute leukemia treated with decitabine

Affiliations
  • 1Division of Hematology/Oncology, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea. wonsik112@gmail.com
  • 2Department of Laboratory Medicine, Inje University Busan Paik Hospital, Busan, Korea.

Abstract

No abstract available.

Keyword

Mixed-phenotype acute leukemia; Decitabine

MeSH Terms

Aged, 80 and over
Antimetabolites, Antineoplastic/*therapeutic use
Azacitidine/*analogs & derivatives/therapeutic use
Biomarkers, Tumor/analysis/genetics
Biopsy
Bone Marrow Examination
Cell Lineage
Female
Humans
Leukemia, Biphenotypic, Acute/*drug therapy/genetics/pathology
Phenotype
Remission Induction
Treatment Outcome
Antimetabolites, Antineoplastic
Azacitidine
Biomarkers, Tumor
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error